SCHEMBL17816136

SCHEMBL17816136

O=C(Nc1ccc(F)c(F)c1)c1ccc(I)c(SC2CCC(C(=O)O)C2)c1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
MAOB P27338 4/20 0.43
LMNA P02545 2/20 0.43
CASP3 P42574 1/20 0.43
SENP8 Q96LD8 1/20 0.43
SENP7 Q9BQF6 1/20 0.43
SENP6 Q9GZR1 1/20 0.43
KCNQ3 O43525 4/20 0.41
KCNQ2 O43526 4/20 0.41
KCNE1 P15382 1/20 0.39
KCNQ1 P51787 1/20 0.39
TSHR P16473 1/20 0.38
MAOA P21397 1/20 0.38
CHRM1 P11229 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DGAT1 O75907 1/20 0.37
SOAT1 P35610 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17816124 0.94 NPC1 (0.46) NPC1RAB9AMAOBLMNACASP3
SCHEMBL17816142 0.93 NPC1 (0.47) NPC1RAB9AMAOBLMNACASP3
SCHEMBL17784114 0.92 NPC1 (0.48) NPC1RAB9AMAOBLMNACASP3
SCHEMBL17816122 0.91 NPC1 (0.47) NPC1RAB9AMAOBKCNQ3KCNQ2
SCHEMBL17816135 0.91 RARA (0.35) NPC1RAB9AMAOBLMNACASP3
SCHEMBL17816184 0.85 NPC1 (0.42) NPC1RAB9AMAOBLMNACASP3
SCHEMBL17792168 0.85 NPC1 (0.50) NPC1RAB9AMAOBLMNACASP3
SCHEMBL17816145 0.85 NPC1 (0.49) NPC1RAB9AMAOBKCNQ3KCNQ2
SCHEMBL17816134 0.85 RARA (0.36) NPC1RAB9AMAOBLMNACASP3
SCHEMBL17816077 0.85 RARA (0.36) NPC1RAB9AMAOBLMNACASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016089990-A1 SULFIDE ALKYL AND PYRIDYL REVERSE SULFONAMIDE COMPOUNDS FOR HBV TREATMENT NOVIRA THERAPEUTICS, INC. (US) 2016-06-09 WO disclosed